Cargando…
Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection
Our understanding of HIV infection has greatly advanced since the discovery of the virus in 1983. Treatment options have improved the quality of life of people living with HIV/AIDS, turning it from a fatal disease into a chronic, manageable infection. Despite all this progress, a cure remains elusiv...
Autores principales: | Agbosu, Esinam E., Ledger, Scott, Kelleher, Anthony D., Wen, Jing, Ahlenstiel, Chantelle L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324444/ https://www.ncbi.nlm.nih.gov/pubmed/35890248 http://dx.doi.org/10.3390/pharmaceutics14071352 |
Ejemplares similares
-
RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency
por: Méndez, Catalina, et al.
Publicado: (2018) -
Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract
por: Zhang, Yuan, et al.
Publicado: (2022) -
Promoter Targeting RNAs: Unexpected Contributors to the Control of HIV-1 Transcription
por: Suzuki, Kazuo, et al.
Publicado: (2015) -
Controlling HIV-1: Non-Coding RNA Gene Therapy Approaches to a Functional Cure
por: Ahlenstiel, Chantelle L., et al.
Publicado: (2015) -
Block and Lock HIV Cure Strategies to Control the Latent Reservoir
por: Ahlenstiel, Chantelle L., et al.
Publicado: (2020)